Henry Schein, Inc. (NASDAQ:HSIC) was the target of unusually large options trading on Wednesday. Stock traders acquired 2,279 put options on the stock. This represents an increase of 2,520% compared to the average daily volume of 87 put options.

A number of institutional investors have recently made changes to their positions in the business. Fuller & Thaler Asset Management Inc. raised its holdings in Henry Schein by 57.1% in the second quarter. Fuller & Thaler Asset Management Inc. now owns 2,200 shares of the company’s stock worth $160,000 after purchasing an additional 800 shares in the last quarter. Kalos Management Inc. raised its holdings in Henry Schein by 6.3% in the second quarter. Kalos Management Inc. now owns 13,615 shares of the company’s stock worth $988,000 after purchasing an additional 807 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund raised its holdings in Henry Schein by 1.8% in the second quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 46,794 shares of the company’s stock worth $3,399,000 after purchasing an additional 846 shares in the last quarter. GHP Investment Advisors Inc. raised its holdings in Henry Schein by 9.8% in the second quarter. GHP Investment Advisors Inc. now owns 10,465 shares of the company’s stock worth $760,000 after purchasing an additional 930 shares in the last quarter. Finally, BB&T Securities LLC raised its holdings in Henry Schein by 26.8% in the first quarter. BB&T Securities LLC now owns 4,676 shares of the company’s stock worth $314,000 after purchasing an additional 988 shares in the last quarter. Institutional investors and hedge funds own 96.65% of the company’s stock.

HSIC stock opened at $84.92 on Thursday. The company has a quick ratio of 0.68, a current ratio of 1.29 and a debt-to-equity ratio of 0.34. The stock has a market capitalization of $12.91 billion, a P/E ratio of 23.59, a PEG ratio of 2.43 and a beta of 0.98. Henry Schein has a 1-year low of $62.56 and a 1-year high of $87.41.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Monday, August 6th. The company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $1.01 by $0.03. The firm had revenue of $3.33 billion during the quarter, compared to the consensus estimate of $3.31 billion. Henry Schein had a return on equity of 20.40% and a net margin of 3.15%. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.88 earnings per share. sell-side analysts anticipate that Henry Schein will post 4.12 EPS for the current fiscal year.

Several analysts have recently weighed in on HSIC shares. BidaskClub upgraded Henry Schein from a “hold” rating to a “buy” rating in a research report on Wednesday, June 13th. Zacks Investment Research upgraded Henry Schein from a “hold” rating to a “buy” rating and set a $85.00 price objective for the company in a report on Tuesday, July 10th. Stifel Nicolaus lifted their price objective on Henry Schein from $76.00 to $81.00 and gave the company a “hold” rating in a report on Tuesday, August 7th. Robert W. Baird lifted their price objective on Henry Schein from $83.00 to $90.00 and gave the company an “outperform” rating in a report on Tuesday, August 7th. Finally, Craig Hallum lifted their price objective on Henry Schein from $83.00 to $96.00 and gave the company a “buy” rating in a report on Tuesday, August 7th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and nine have given a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $84.11.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

See Also: Day Trading – Risk Worth the Reward?

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.